Search results
Vanguard Health Care Fund's Strategic Moves in Q1 2024: A Focus on Pfizer Inc
GuruFocus.com via Yahoo Finance· 2 days agoThe top holdings were 8.97% in Eli Lilly and Co (NYSE:LLY), 6.45% in UnitedHealth Group Inc...
Moderna posts better-than-expected quarterly results as it looks to fall RSV vaccine launch
Market Watch· 3 days agoModerna Inc. on Thursday reported a narrower-than-expected first-quarter loss as the COVID vaccine...
Pharma R&D productivity seen improving for the first time in years
Seeking Alpha· 16 hours agoDiscover the latest findings on the return on investment from pharmaceutical...
Childhood Vaccination: Why It’s Important for Your Children and Community
KTBS Shreveport· 5 days agoThe increased risk of outbreaks can be largely attributed to the drop in pediatric vaccination rates...
Pfizer’s first-quarter results top estimates, while drugmaker boosts full-year profit outlook
Market Watch· 4 days agoAn expected drop in COVID-19-related product sales, including antiviral Paxlovid and vaccine...
Vanguard Health Care Fund's Strategic Moves in Q1 2024: A Focus
Guru Focus· 2 days agoInsight into the Fund's Latest Investment Decisions and Stock Adjustments Vanguard Health Care Fund...
Sentynl Therapeutics Announces Global Acquisition of Zokinvy® (Lonafarnib) for Treatment of...
KTLA-TV Los Angeles· 2 days agoSentynl, a Zydus Group company, receives worldwide proprietary rights to Zokinvy, adding to portfolio of biopharmaceuticals for rare and ultra-rare diseases Zokinvy is approved in the U.S. ( ...
Pfizer's first-quarter results top estimates, while drugmaker boosts full-year profit outlook
Morningstar· 4 days agoPfizer Inc. on Wednesday reported first-quarter profit and sales that beat analyst expectations and raised its full-year earnings guidance as cancer and heart-disease drugs helped offset plummeting ...